[
  {
    "ts": null,
    "headline": "Biogen (BIIB) Valuation Check As Shares Trade Below Analyst Targets And Long Term Returns Stay Under Pressure",
    "summary": "Recent performance snapshot Biogen (BIIB) shares closed at US$171.59, with performance mixed across recent periods. The stock shows a 1 day return of about a 1% decline, a 4.4% gain over the past week, and a 3.1% decline over the past month. Over the past 3 months, Biogen has returned 15.1%, while year to date the stock is down 3.5%. Over longer horizons, the 1 year total return is 15.3%, compared with declines of 40.0% and 38.4% over the past 3 and 5 years, respectively. See our latest...",
    "url": "https://finnhub.io/api/news?id=408d44e0c1329b7396ec8860f4d074fa87504c34856f500ef90c8a764b519da4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769425756,
      "headline": "Biogen (BIIB) Valuation Check As Shares Trade Below Analyst Targets And Long Term Returns Stay Under Pressure",
      "id": 138260511,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BIIB",
      "source": "Yahoo",
      "summary": "Recent performance snapshot Biogen (BIIB) shares closed at US$171.59, with performance mixed across recent periods. The stock shows a 1 day return of about a 1% decline, a 4.4% gain over the past week, and a 3.1% decline over the past month. Over the past 3 months, Biogen has returned 15.1%, while year to date the stock is down 3.5%. Over longer horizons, the 1 year total return is 15.3%, compared with declines of 40.0% and 38.4% over the past 3 and 5 years, respectively. See our latest...",
      "url": "https://finnhub.io/api/news?id=408d44e0c1329b7396ec8860f4d074fa87504c34856f500ef90c8a764b519da4"
    }
  }
]